Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Other Non-Current Liabilities (2016 - 2025)

Integra Lifesciences Holdings' Other Non-Current Liabilities history spans 17 years, with the latest figure at $204.3 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 39.69% year-over-year to $204.3 million; the TTM value through Dec 2025 reached $204.3 million, up 39.69%, while the annual FY2025 figure was $204.3 million, 39.69% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $204.3 million at Integra Lifesciences Holdings, down from $233.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $253.2 million in Q2 2025 and bottomed at $25.0 million in Q4 2022.
  • The 5-year median for Other Non-Current Liabilities is $146.2 million (2024), against an average of $144.9 million.
  • The largest annual shift saw Other Non-Current Liabilities crashed 79.21% in 2022 before it soared 123.37% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $120.3 million in 2021, then plummeted by 79.21% to $25.0 million in 2022, then soared by 469.41% to $142.4 million in 2023, then grew by 2.73% to $146.2 million in 2024, then soared by 39.69% to $204.3 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Other Non-Current Liabilities are $204.3 million (Q4 2025), $233.3 million (Q3 2025), and $253.2 million (Q2 2025).